Biogen (BIIB)
(Delayed Data from NSDQ)
$228.72 USD
+4.26 (1.90%)
Updated Jun 27, 2024 04:00 PM ET
After-Market: $228.84 +0.12 (0.05%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth B Momentum B VGM
Price, Consensus and EPS Surprise
BIIB 228.72 +4.26(1.90%)
Will BIIB be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for BIIB based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for BIIB
FDA Accepts Ionis' (IONS) NDA for Rare Disease Drug Olezarsen
La-Z-Boy and Winnebago have been highlighted as Zacks Bull and Bear of the Day
BIIB: What are Zacks experts saying now?
Zacks Private Portfolio Services
Is Eli Lilly (LLY) a Buy on Tirzepatide Success in Sleep Apnea?
Is the Options Market Predicting a Spike in Biogen (BIIB) Stock?
Biogen Inc. (BIIB) is a Top-Ranked Momentum Stock: Should You Buy?
Other News for BIIB
“LEQEMBI®” (Lecanemab) for the Treatment of Alzheimer’s Disease Launched in China
August 9th Options Now Available For Biogen (BIIB)
Biogen's Lecanemab launched in China to treat Alzheimer's Disease
Biogen's Lecanemab launched in China to treat Alzheimer's Disease Use symbol Eisai
Forecasting The Future: 19 Analyst Projections For Biogen